New Migraine and Headache Information from the AHS Scientific Meeting
Ellen and I have just returned from a week in Los Angeles and an unparallel opportunity to learn more about migraine and other headache disorders. We attended the annual scientific meeting of the American Headache Society. This is an annual meeting designed for doctors and other health care professionals to attend continuing medical education (CME) sessions and learn more about migraines and headaches, including presentations about new research and upcoming treatments. As patient educators and advocates, we were able to attend the CME sessions and learn along with many of the same migraine and headache specialists to whom we all turn for expert treatment.
There were so many great sessions at this conference! Dr. Nicholson was there as well, and we'll be writing about what we learned for quite some time. This morning, I thought you'd like a preview of some the topics about which we'll be writing so we can share what we learned:
- genetics and headache disorders
- comorbidities of migraine in children and adolescents
- Do comorbidities differ by headache and migraine type?
- comorbidities that predict migraine progression
- sports concussion
- the latest in migraine and headache research
- refractory migraine and headache
- medications we already have - delivered differently
- new treatments delivered by unusual methods
- migraine in childhood and adolescence
- migraine in adults
- migraine in older adults
- the burden chronic migraine puts on families
- differences in disability due to neck pain in migraine and chronic migraine
- the effects of demographic and socioeconomic characteristics on the barriers to the diagnosis and treatment of chronic migraine
- the use of triptans for hemiplegic migraine and migraine with brainstem aura (formerly called basilar-type migraine)
- the use of corticosteroids in migraine treatment
- evaluation of migraine trigger site deactivation surgery
- comorbidities and predictive factors in new daily persistent headache (NDPH)
- much more!
The forecasts reported that the weather was great in Los Angeles. I can't speak for Ellen or Dr. Nicholson, but I didn't really find enough time to anywhere outside the conference hotel to be sure.
In addition to the regularly scheduled conference sessions, Ellen and I attended two extra sessions - one at 6:30 a.m. and one at 6:30 p.m. We also did find time to talk with some of the many migraine and headache specialists at the conference and catch up a bit with what they're working on.
Something Ellen and I both found exciting was the opportunity to actually see one of the SpringTMS devices, which were recently approved by the FDA for the acute treatment of migraine with aura. Patients will begin having access to this device this summer. We couldn't use it, but we were able to get our hands on one, turn it on, and see how it works.
As we publish articles / blog entries about what we learned at the conference, we hope you'll feel free to post comments on them and discuss the topics with us. We can all learn from the discussions too.
Make a difference... Donate to the 36 Million Migraine Campaign!
© Teri Robert, 2014, • Last updated July 7, 2014.